Immune Design CS
(IMDZ)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Sales | 1,938 | 1,800 | 3,544 | 1,064 | 25 |
| Cost of Goods | 79 | 575 | 31 | 18 | 14 |
| Gross Profit | 1,859 | 1,225 | 3,513 | 1,046 | 11 |
| Operating Expenses | 11,344 | 14,921 | 10,101 | 5,751 | 5,538 |
| Operating Income | -9,406 | -13,121 | -6,557 | -4,687 | -5,513 |
| Other Income | 0 | 1 | -125 | -1,439 | -2,710 |
| Pre-tax Income | -9,406 | -13,120 | -6,682 | -6,126 | -8,223 |
| Net Income Continuous | -9,406 | -13,120 | -6,682 | -6,126 | -8,223 |
| Net Income | $-9,406 | $-13,120 | $-6,682 | $-6,126 | $-8,223 |
| EPS Basic Total Ops | -0.56 | 34.81 | -0.55 | -16.57 | -22.25 |
| EPS Basic Continuous Ops | -0.56 | 34.80 | -0.55 | -16.56 | -22.25 |
| EPS Diluted Total Ops | -0.56 | 34.81 | -0.55 | -16.57 | -22.25 |
| EPS Diluted Continuous Ops | -0.56 | 34.80 | -0.55 | -16.56 | -22.25 |
| EBITDA(a) | $-9,354 | $-13,060 | $-6,502 | $-4,626 | $-5,452 |